Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of KRAS gene mutations in chronic myeloid leukemia in Iran.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2014

Kooshyar Mohammad Mahdi, Ayatollahi Hossein, Keramati Mohammad Reza, Sadeghian Mohammad Hadi, Miri Mohsen, Sheikhi Maryam

Abstract excerpt

BACKGROUND: The single most common proto-oncogene change in human neoplasms is a point mutation in RAS genes. A wide range of variation in frequency of KRAS mutations has been seen in hematologic malignancies. Despite this, RAS roles in leukemogenesis remain unclear. The frequency of KRAS mutatio...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ras Proteins
Share to Cross-Sectional Studies
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Polymorphism, Restriction Fragment Length

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 24377583
DOI: 10.7314/apjcp.2013.14.11.6653

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24377583-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of KRAS gene mutations in chronic myeloid leukemia in Iran.PMID 24377583Read ↗

Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemia.Semantic proximity Read ↗

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.Semantic proximity Read ↗

RAS mutations in acute myeloid leukaemia patients: A review and meta-analysis.Semantic proximity Read ↗

The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.Semantic proximity Read ↗

RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group.Semantic proximity Read ↗

NRAS mutations in de novo acute leukemia: prevalence and clinical significance.Semantic proximity Read ↗

RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia.Semantic proximity Read ↗

RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia.Semantic proximity Read ↗

Chronic myelocytic leukemia with myeloblastoma has higher frequency of ras oncogene mutation.Semantic proximity Read ↗

BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild‐type RASSemantic proximity Read ↗

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsSemantic proximity Read ↗

Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.